Trental for the Treatment of Vertigo/Dizziness/Imbalance
Status:
Completed
Trial end date:
2021-04-12
Target enrollment:
Participant gender:
Summary
Imbalance, dizziness and vertigo as a result of problems in the inner ear (vestibular
dysfunction) are becoming increasingly more prevalent in Americans 40 years of age and older.
The symptoms have a severe impact on affected individuals with detrimental effects on work,
travel, social and family life. These patients see doctors often with no relief in their
symptoms.
The most promising help for these patients is to use medication that will increase blood flow
to the inner ear. Pentoxifylline (Trental) has been shown to increase microvascular blood
flow.